Brainvectis at NeurATRIS annual meeting 2017

By January 12, 2018Non class

On november 21st,  Head of preclinical research Dr. Sandro Alves presented Brainvectis as an example of  spin-off translating academic preclinical research into industrial development.

NeurATRIS is a research infrastructure conceived to accelerate the translation of discoveries in basic research into medical innovations for the treatment of diseases of the nervous system.